Skip to main content

Illumina, Covaris Ink Co-marketing Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Covaris announced today that it has signed a co-marketing deal with Illumina related to sequencing sample preparation.

Under the agreement, the firms will co-market Covaris' DNA shearing technologies with Illumina's next-generation sequencing product lines including the HiSeq, HiScanSQ, and Genome Analyzer.

According to Woburn, Mass.-based Covaris, its technology "enables higher recoveries for nucleic acid extraction, tissue homogenization, chromatin shearing, protein digestion, and cell lysis." It also is isothermal and non-contact, which ensures molecular stability.

Financial and other terms of the alliance were not disclosed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.